Home About Us News Screening Diagnosis Treatment Patient Information Education
Contact Us
Educational Articles
Breast Cancer FAQs
Breast Self Exams
Breast Pain / Mastalgia
Gynecomastia
BRCA Testing
Fibrocystic Breast Changes
Open Breast Biopsies
Benefits of SAVI
Molecular Subtyping
Adjuvant Therapy
HALO Breast Pap Test
Inflammatory Breast Cancer
Locally Advanced Breast Cancer
Radiation Treatment for Early Stage
Sentinel Lymph Node Biopsy
Stereotactic Core Needle Biopsy
Non-Invasive Breast Cancer
No Prissy Shoes
Clinical Trials
American Society of Breast Surgery Mammo
University of Louisville Sentinel Lymph
NSABP, B39, B40 Clinical Trials
Taylor Rx Trial
Types of Breast Cancer
In Situ Breast Cancer
Invasive Breast Cancer
Locally Advanced Breast Cancer
Inflammatory Breast Cancer
Metastatic Breast Cancer
Frequently Asked Questions
What is Breast Pain/Mastalgia?
What is Lobular Carcinoma is Situ?
What is Atypical Ductal Hyperplasia?
What are Estrogen and Progesterone recep
What is the HER-2/neu test?
What is Whole Breast Irradiation?
What is Partial Breast Irradiation?
What are the reconstruction options?
Why do we give chemotherapy?
What is Tamoxifen?
What Is Ductal Carcinoma in Situ?
Are there prognostic indicators?
Are there different types?
What is Nipple Discharge?
What is Breast Cancer?
How does Breast Cancer spread?
Who gets Breast Cancer?
What are the chances?
Does race play a role in incidence?
What are fibrocystic changes?
What are the physical signs?
How is Breast Cancer staged?
What are the Aromatase inhibitors?
Diagnosis
Screening
Treatment
Locally Advanced Breast Cancer
Locally Advanced Breast Cancer
 
In 2005, there were over 211,000 women diagnosed with breast cancer in the United States. Of these, 10 - 15 % were categorized as locally advanced breast cancers (LABC). These cancers are considered inoperable or not curable by any existing surgical technique available today. They are large cancers that are greater than five centimeters in diameter, can be involved with the breast skin, fixed to the chest wall, or have fixed or matted axillary lymph node involvement. They can also involve the infra or supraclavicular lymph nodes as well. According to the Joint Commission on Cancer, these tumors are categorized as T3 or T4 cancers with the axillary lymph nodes referred to as N1,N2 or N3 disease. Clinically they are then staged as III a, b, or c tumors. These tumors are most commonly found in African American, Hispanic, and Native American women due to socioeconomic status...Read more here.

hello